Based on the above results, ANXA1, ANXA2, ANXA3, ANXA5, ANXA6, ANXA8, and ANXA13 were identified as potential genes related to basal-subtype bladder cancer (ANXA-B), and ANXA4, ANXA9, ANXA10, and ANXA11 were defined as luminal-subtype bladder cancer-related genes (ANXA-L). This evidence concerns the gene ANXA13 and urinary bladder carcinoma.